Back to Search
Start Over
163TiP ICE study: Combination of irinotecan plus cetuximab and envafolimab as a rechallenge regimen in RAS/BRAF WT/MSS mCRC.
- Source :
-
Annals of Oncology . 2024 Supplement 1, Vol. 35, pS73-S73. 1p. - Publication Year :
- 2024
- Subjects :
- *IRINOTECAN
*CETUXIMAB
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 178046044
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.05.173